Shanti Balkissoon-Castillo, DPM
Foot & Ankle Surgery · Albuquerque, NMNPI 1063418556
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,963 of the $3,713 with a category attached, or 79.8%. 17 manufacturers reported payments, led by Nevro Corp. at 42.5% of the total. Reporting peaked in 2022 at $1,715 and has fallen 71.9% since, to $482 in 2025.
Across 107 payments — averaging $34.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Kerecis Limited$636
- Smith+Nephew$563
- AbbVie$165
- Treace Medical Concepts, Inc.$129
- Organogenesis Inc.$126
- plus $516 from 11 others
What the payments were for
- Travel & lodging$74920%
- Food & beverage$2,96380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 16 | $1,577 |
| Kerecis Limited | 11 | $636 |
| Smith+Nephew | 31 | $563 |
| AbbVie | 4 | $165 |
| Treace Medical Concepts, Inc. | 3 | $129 |
| Organogenesis Inc. | 6 | $126 |
| Orthofix Medical, Inc. | 13 | $116 |
| DJO, LLC | 7 | $110 |
| Paratek Pharmaceuticals, Inc. | 3 | $52 |
| Bioventus LLC | 3 | $43 |
| Vertex | 2 | $40 |
| Tactile Systems Technology Inc | 2 | $38 |
| Stryker(2 entities) | 2 | $34 |
| Medtronic | 1 | $26 |
| Celularity Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$1,073
- Kerecis Omega3 Marigen$958
- Kerecis SurgiClose$613
- Kerecis Omega3 SurgiClose$276
- Kerecis GraftGuide$153
- Kerecis Omega3 GraftGuide$148
- Omnia$127
- Santyl$112
- REGRANEX$112
- Oasis$112
- DALVANCE$103
How this compares
$3,713 in reported general payments places this provider in the 60th percentile of 69 foot & ankle surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other foot & ankle surgery in Albuquerque
- Mark MargiottaAlbuquerque$12K
- Jason DunnAlbuquerque$10K
- Alexander JenksAlbuquerque$9K
- Marshall MonsonAlbuquerque$9K
- Chad SmithAlbuquerque$9K
- Mark TennyAlbuquerque$8K
- Eve HuiAlbuquerque$6K
- Haywan ChiuAlbuquerque$5K
- Steven WregeAlbuquerque$4K
- Shama PervaizAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.